Scolaris Content Display Scolaris Content Display

Fotocoagulación con láser para la neovascularización coroidal de la miopía patológica

Contraer todo Desplegar todo

Referencias

References to studies included in this review

Ir a:

Brancato 1988 {published data only}

Brancato R, Menchini U, Pece A, Capoferri C, Avanza P, Radrizzani E. Dye laser photocoagulation of macular subretinal neovascularization in pathological myopia. A randomized study of three different wavelengths. International Ophthalmology 1988;11(4):235‐8.

Fardeau 1992 {published data only}

Fardeau C, Soubrane G, Coscas G. [Photocoagulation de néo‐vessaux sous‐rétinien compliquant la dégénérescence myopique]. Bulletin des Societes d'Ophtalmologie de France 1992;3:239‐42.
Soubrane G, Pisan J, Bornert P, Perrenoud F, Coscas G. [Néovaisseaux sous‐rétiniens de la myopie dégénérative: rèsultats de la photocoagulation]. Bulletin des Societes d' Ophtalmologie de France 1986;86:269‐72.

Additional references

Ir a:

Adelberg 1995

Adelberg DA, Del Priore LV, Kaplan HJ. Surgery for subfoveal membranes in myopia, angioid streaks, and other disorders. Retina 1995;15(3):198‐205.

Avila 1984

Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schepens CL. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 1984;91(12):1573‐81.

Brancato 1990

Brancato R, Pece A, Avanza P, Radrizzani E. Photocoagulation scar expansion after laser therapy for choroidal neovascularization in degenerative myopia. Retina 1990;10(4):239‐43.

Cohen 1996

Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ. Etiology of choroidal neovascularization in young patients. Ophthalmology 1996;103(8):1241‐4.

Curtin 1985

Curtin BJ. The Myopias. Basic Science and clinical management. Philadelphia: Harper and Row, 1985:7‐10.

Ferris 1982

Ferris FL, Kassoff A, Bresnick G, Bailey I. New visual acuity charts for clinical research. American Journal of Ophthalmology 1982;94(1):91‐6.

Fine 1986

Fine AM, Elman MJ, Ebert JE, Prestia PA, Starr JS, Fine SL. Earliest symptoms caused by neovascular membranes in the macula. Archives of Ophthalmology 1986;104(4):513‐4.

Fleury 1983

Fleury I, De Laey JJ. Prognosis of the disciform response in high myopia. Bulletin de la Societe Belge d' Ophtalmologie 1983;206:91‐102.

Fredrick 2002

Fredrick DR. Myopia. BMJ 2002;324(7347):1195‐9.

Glanville 2006

Glanville JM, Lefebvre C, Miles JN, Camosso‐Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130‐6.

Hampton 1983

Hampton RG, Kohen D, Bird AC. Visual prognosis of disciform degeneration in myopia. Ophthalmology 1983;90(8):923‐6.

Higgins 2006

Higgins JPT, Green S, editors. Assessment of quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Section 6. In: The Cochrane Library, Issue 4, 2006. John Wiley & Sons, Ltd. Chichester.

Hotchkiss 1981

Hotchkiss ML, Fine SL. Pathologic myopia and choroidal neovascularization. American Journal of Ophthalmology 1981;91(2):177‐83.

Klaver 1988

Klaver CCW, Wolfs RCW, Vingerling JR, Hofman A, de Jong PTVM. Age‐Specific Prevalence and Causes of Blindness and Visual Impairment in an Older Population. The Rotterdam Study. Archives of Ophthalmology 1998;116(5):653‐8.

Kleinstein 2003

Kleinstein RN, Jones LA, Hullett S, Kwon S, Lee RJ, Friedman NE, et al. Refractive error and ethnicity in children. Archives of Ophthalmology 2003;121(8):1141‐7.

Lin 2001

Lin LL, Shih YF, Hsiao CK, Chen CJ, Lee LA, Hung PT. Epidemiologic study of the prevalence and severity of myopia among schoolchildren in Taiwan in 2000. Journal of the Formosan Medical Association 2001;100(10):684‐91.

Mangione 1998

Mangione CM, Berry S, Spritzer K, Janz NK, Klein R, Owsley C, et al. Identifying the content area for the 51‐item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Archives of Ophthalmology 1998;116(2):227‐33.

Mangione 1999

Mangione CM, Gutierrez PR, Lowe G, Orav EJ, Seddon JM. Influence of Age‐related maculopathy on visual functioning and health‐related quality of life. American Journal of Ophthalmology 1999;128(1):45‐53.

McClure 2000

McClure ME, Hart PM, Jackson AJ, Stevenson MR, Chakravarthy U. Macular degeneration: do conventional measurements of impaired visual function equate with visual disability?. British Journal of Ophthalmology 2000;84:244‐50.

Miller 2001

Miller DG, Singerman LJ. Natural history of choroidal neovascularization in high myopia. Current Opinion in Ophthalmology 2001;12(3):222‐4.

MPS 1991a

Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy: Five‐year results from randomized clinical trials. Archives of Ophthalmology 1991;109:1109‐14.

MPS 1991b

Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesion in age‐related macular degeneration: results of a randomized clinical trial. Archives of Ophthalmology 1991;109(9):1220‐31.

MPS 1991c

Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesion in age‐related macular degeneration: results of a randomized clinical trial. Archives of Ophthalmology 1991;109(9):1232‐41.

MPS 1993

Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age‐related macular degeneration: updated findings from two clinical trials. Archives of Ophthalmology 1993;111:1200‐9.

Nicolosi 1994

Nicolosi A, Marighi PE, Rizzardi P, Osella A, Miglior S. Prevalence and causes of visual impairment in Italy. International Journal of Epidemiology 1994;23(2):359‐64.

Ohno‐Matsui 2003

Ohno‐Matsui K, Yoshida T, Futagami S, Yasuzumi K, Shimada N, Kojima A, et al. Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. British Journal of Ophthalmology 2003;87(5):570‐3.

Secrétan 1997

Secrétan M, Kuhn D, Soubrane G, Coscas GJ. Long‐term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment. European Journal of Ophthalmology 1997;7(4):307‐16.

Soubrane 1986

Soubrane G, Pisan J, Bornert P, Perrenoud F, Coscas G. [Néovaisseaux sous‐rétiniens de la myopie dégénérative: rèsultats de la photocoagulation]. Bulletin des Societes d' Ophtalmologie de France 1986;86:269‐72.

Sperduto 1983

Sperduto RD, Seigel D, Roberts J, Rowland M. Prevalence of myopia in the United States. Archives of Ophthalmology 1983;101(3):405‐7.

Tabandeh 1999

Tabandeh HT, Flynn HW, Scott IU, Lewis ML, Rosenfeld PJ, Rodriguez F, et al. Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization. Ophthalmology 1999;106(11):2063‐7.

Tano 2002

Tano Y. Pathologic myopia: where are we now?. American Journal of Ophthalmology 2002;134(5):645‐60.

Thomas 1994

Thomas MA, Dickinson JD, Melberg NS, Ibanez HE, Dhaliwal RS. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology 1994;101(8):1384‐96.

VIP 2001

Verteporfin in Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1‐year results of a randomised clinical trials‐VIP report No. 1. Ophthalmology 2001;108(5):841‐52.

VIP 2003

Verteporfin in Photodynamic Therapy (VIP) Study Group. Verteporfin Therapy of Subfoveal Choroidal Neovascularization in Pathologic Myopia 2‐year Results of a Randomized Clinical Trial ‐ VIP Report No 3. Ophthalmology 2003;110(4):667‐73.

Zhang 2005

Zhang S, Wang K, Wang L, Zhu C, Zhang L, Shi H. Transpupillary thermotherapy for choroidal neovascularization. Chinese Ophthalmic Research 2005;23(3):322‐24.

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Brancato 1988

Methods

Randomisation based on a list of random numbers.
Assignment by study personnel other than the treating physician
No masking of participants, physicians. Masking of outcome assessors

Participants

Setting: Italy
Number of participants: 26 (27 eyes)
Mean age: 44
Gender: 21 females
Inclusion criteria: myopia ‐6D or worse; age over 60; visual acuity 20/200 (6/60) or more; choroidal neovascularisation 100 to 400 microns from the foveola
Different follow up of participants (3 to 17 months) not taken into account in analyses

Interventions

Laser photocoagulation of the choroidal neovascularisation with 3 different wavelengths:
(1) 577 nm
(2) 590 nm
(3) 620 nm

Outcomes

Distance acuity; Recurrence during follow up

Notes

Funding sources: not described

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate
Fardeau 1992

Methods

Randomisation based on a list of random numbers in sealed envelopes
No masking of participants, physicians. Masking of outcome assessors

Participants

Setting: France
Number of participants: 70 (70 eyes)
Gender: 46 females
Inclusion criteria: myopia ‐5D or worse with myopic fundus changes; age over 60; visual acuity 20/200 (6/60) or more; choroidal neovascularisation 100 to 400 microns from the foveola
Different follow up of participants (6 to 48 months) not taken into account in analyses; selective loss to follow up of controls at the second time point (30 treated versus 17 controls)

Interventions

(1) Krypton 647 nm 200 micron laser spots with 0.2 second duration on choroidal neovascularisation or its recurrence
(2) Observation

Outcomes

Near acuity and distance acuity at two follow up time points (1985 and 1990)

Notes

Funding sources: not described

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

Table 1. Summary of study results

Study ID

Follow‐up length

Outcome

Wavelength

n/N

Brancato 1988

3 to 17 months

Loss 2+ Snellen lines

577 nm

2/9

590 nm

3/9

620 nm

3/9

Fardeau 1992

6 to 48 months

Final VA of 20/100 or worse

Krypton 647 nm

16/35

No treatment (control group)

31/35
Figuras y tablas -
Table 1. Summary of study results
Ir a la tabla de la revisión